Abstract
Aberrant expression of the amyloid precursor protein (APP) gene may contribute to the β-amyloid deposition seen in Alzheimer’s disease and Down syndrome patients. Genomic DNA was isolated from human brain tissue and digested withHpaII, an enzyme sensitive to CpG methylation. Southern-blot analysis revealed the absence of methylation at a site in the APP gene of an Alzheimer’s disease subject. This site was methylated in a nondemented subject and a subject with a non-Alzheimer’s type of dementia (Pick’s disease). This is the first report of an epigenetic defect in an Alzheimer’s disease patient and the observation suggests that hypomethylation of the APP gene may be one of several factors contributing to aberrant gene expression in Alzheimer’s disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ashall F. and Goate A. M. (1994) Role of the beta-amyloid precursor protein in Alzheimer’s disease.Trends Biochem. Sci. 19, 42–46.
Bendotti C., Forloni G. L., Morgan F. A., O’Hara B. F., Oster-Granite M.-L., Reeves R. H., Gearhart J. D., and Coyle J. T. (1988) Neuroanatomical localization and quantification of amyloid precursor protein mRNA byin situ hybridization in the brains of normal, aneuploid, and lesioned mice.Proc. Natl. Acad. Sci. USA 85, 3628–3632.
Bird A. P. (1986) CpG-rich islands and the function of DNA methylation.Nature 321, 209–213.
Brandeis M., Kafri T., Ariel M., Chaillet J. R., McCarrey J., Razin A., and Cedar H. (1993) The ontogeny of allele-specific methylation associated with imprinted genes in the mouse.EMBO J. 12(9), 3669–3677.
Davidson J. S., West R. L., Kotikalapudi P., and Maroun L. E. (1992) Sequence and methylation in the β/A4 region of the rabbit amyloid precursor protein gene.Biochem. Biophys. Res. Commun. 188(2), 905–911.
Gardiner-Garden M. and Frommer M. (1987) CpG islands in vertebrate genomes.J. Mol. Biol. 196, 261–282.
Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., and Hardy J. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease.Nature 349, 704–706.
Haass C. and Selkoe D. J. (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide.Cell 75, 1039–1042.
Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., and Müller-Hill B. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor.Nature 325, 733–736.
Khachaturian Z. S. (1985) Diagnosis of Alzheimer’s disease.Arch. Neurol. 42, 1097–1105.
Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., and Ito H. (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity.Nature 331, 530–532.
Larsen F., Solheim J., and Prydz H. (1993) A methylated CpG island 3′ in the apolipoprotein E gene does not repress its transcription.Hum. Mol. Genet. 2(6), 775–780.
Ledoux S., Nalbantoglu J., and Cashman N. R. (1994) Amyloid precursor protein gene expression in neural cell lines: influence of DNA cytosine methylation.Mol. Brain Res. 24, 140–144.
Lieman-Hurwitz J., Dafni N., Lavie V., and Gromer Y. (1982) Human cytoplasmic superoxide dismutase cDNA clone: a probe for studying the molecular biology of Down syndrome.Proc. Natl. Acad. Sci. USA 79, 2808–2811.
Mann D. M. (1988) The pathological association between Down syndrome and Alzheimer disease.Mech. Aging Dev. 43(2), 99–136.
Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F., and Cordell B. (1988) A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors.Nature 331, 525–527.
Rodenhiser D. I., Coulter-Mackie M. B., and Singh S. M. (1993) Evidence of DNA methylation in the neurofibromatosis type 1 (NFT1) gene region 17q11.2.Hum. Mol. Genet. 2(4), 439–444.
Rogaev E. I., Lukiw W. J., Lavrushina O., Rogaeva E. A., and St. George-Hyslop P. H. (1994) The upstream promoter of the β-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain.Genomics 22, 340–347.
Salbaum J. M., Weidemann A., Lemaire H. G., Masters C. L., and Beyreuther K. (1988) The promoter of Alzheimer’s disease amyloid A4 precursor protein.EMBO J. 7(9), 2807–2813.
Selkoe D. J. (1993) Physiological production of the beta-amyloid protein and the mechanism of Alzheimer’s disease.Trends Neurosci. 16(10), 403–409.
Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A. P., St. George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., and Neve R. L. (1987) Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.Science 235, 880–884.
West R. L. and Maroun L. E. (1992) CGISLE: a program for CG island detection in DNA sequence data.Biotechniques 13(6), 912,913.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
West, R.L., Lee, J.M. & Maroun, L.E. Hypomethylation of the amyloid precursor protein gene in the brain of an alzheimer’s disease patient. J Mol Neurosci 6, 141–146 (1995). https://doi.org/10.1007/BF02736773
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02736773